Iterum Therapeutics Plc

( )
ITRM After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -6.73%146.810.0%$1548.66m
OCGNOcugen, Inc. -4.19%9.600.0%$1117.49m
NVAXNovavax, Inc. -14.27%205.9992.9%$889.13m
AMGNAmgen, Inc. -0.60%225.691.3%$548.61m
VRTXVertex Pharmaceuticals, Inc. 0.80%212.061.9%$521.66m
REGNRegeneron Pharmaceuticals, Inc. -1.77%454.862.7%$518.70m
ILMNIllumina, Inc. -1.23%441.013.5%$513.82m
GILDGilead Sciences, Inc. 0.88%63.011.0%$483.74m
ALXNAlexion Pharmaceuticals, Inc. -1.05%150.372.0%$354.48m
BNGOBionano Genomics, Inc. -3.66%9.480.0%$350.38m
BIIBBiogen, Inc. -1.24%269.851.7%$329.09m
CRSPCRISPR Therapeutics AG -0.37%129.770.6%$308.42m
EXASEXACT Sciences Corp. -2.72%136.3918.4%$255.23m
SGENSeagen Inc. 0.76%153.715.8%$212.10m
VXRTVaxart, Inc. -5.43%7.140.0%$197.89m

Company Profile

Iterum Therapeutics Plc is a pharmaceutical company, which engages in the development and commercialization of sulopenem to be potentially the first and only oral and intravenous (IV) branded penem available. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland.